For nearly 100 years, we’ve been accelerating the journey to better diabetes care. With the creation of the first insulin delivery device, we delivered an innovation that moved the management and treatment of diabetes forward.
embecta offers safety products aligned to the most recent insulin delivery recommendations published in the Mayo Clinic Proceedings
and ADA Standards of Care, which support the use of shorter needles for insulin delivery. Evidence suggests that shorter needles may
lower the risk of intramuscular (IM) injection, which is associated with frequent and unexplained hypoglycemia.